Germany leads the global blood and blood-forming organs medicine sales with $7.63 billion, experiencing a YoY growth of 11.95% in 2023. Spain follows with $2.31 billion, and a modest growth of 3.57%. Notable growth rates are seen in Iceland and Mexico with 11% and 9.37% respectively. Most other countries experience moderate YoY growth.
Future trends to consider include:
- The expansion of healthcare infrastructure in emerging markets, which could increase demand in Mexico and similar countries.
- Technological advancements in blood disorder treatments potentially driving growth in established markets like Germany and Spain.
- Ongoing global health crises influencing trends due to disruptions in supply and demand dynamics.
Top countries in Blood and Blood Forming Organs Medicine Sales by Country
| # | 10 Countries | Million US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 7,630 | 2023 | +9.89% | +11.95% | View data |
| 2 | 2 Spain | 2,310 | 2023 | +4.73% | +3.57% | View data |
| 3 | 3 Austria | 532.1 | 2023 | +6.31% | +6.1% | View data |
| 4 | 4 Switzerland | 515.7 | 2023 | +8.23% | +5.44% | View data |
| 5 | 5 Finland | 388.2 | 2023 | +5.12% | +6.68% | View data |
| 6 | 6 Portugal | 321.8 | 2023 | +0.85% | +3.87% | View data |
| 7 | 7 Mexico | 113.9 | 2023 | +0.088% | +9.37% | View data |
| 8 | 8 Slovenia | 87 | 2023 | +4.32% | +6.23% | View data |
| 9 | 9 New Zealand | 82.3 | 2023 | +3% | +8.28% | View data |
| 10 | 10 Estonia | 50.8 | 2023 | +4.96% | +3.88% | View data |
